Couverture de Dawnzera's EU Approval, Medtronic's Investment in Anteris, and DEI Trends in Life Sciences

Dawnzera's EU Approval, Medtronic's Investment in Anteris, and DEI Trends in Life Sciences

Dawnzera's EU Approval, Medtronic's Investment in Anteris, and DEI Trends in Life Sciences

Écouter gratuitement

Voir les détails

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

 In this episode, we explore the latest developments in the healthcare and pharmaceutical industries. The European Commission has approved Otsuka's Dawnzera for preventing recurrent attacks in hereditary angioedema, a rare disease, marking a significant advancement in treatment options. Medtronic plans a substantial investment in Anteris Technologies, contingent on a successful public stock offering, to support the development of the DurAVR aortic heart valve. Meanwhile, life sciences companies are increasingly rejecting proposals against diversity, equity, and inclusion initiatives, recognizing their strategic importance. Anamika Shrimali shares her experience with the HPV vaccine, highlighting the need for better vaccine accessibility and awareness. Mayo Clinic's Ugur Sener and Taylor Galloway introduce an innovative approach to brain cancer care through the Neuro-Oncology Anywhere clinical trial portfolio. Taconic Biosciences enhances its research capabilities by acquiring TransCure bioServices, strengthening its platform for humanized mouse translational research. In other news, GE HealthCare and Epic Systems navigate challenges in AI investment and antitrust allegations, while health insurance executives face congressional scrutiny. Finally, the evolution of global trial strategies is reshaping clinical research, emphasizing collaboration and technological integration to enhance patient care and medical advancements. Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! Stan Berteloot is a French-American journalist, marketing strategist, and AI expert based in Princeton, New Jersey. A University of Maryland journalism graduate, he navigates the intersection of storytelling, technology, and culture. As Head of Strategy and CTO at Nytro Marketing, he pioneered AI-driven content creation, launching the AI in Marketing podcast. He also hosts Back in America, a podcast exploring American identity through in-depth conversations on race, misinformation, and AI ethics. Start your VoiceStream free trial today! 📚 Sources: https://pharmaphorum.com/news/eu-approves-otsukas-long-acting-hae-drug-dawnzerahttps://www.medtechdive.com/news/medtronic-buy-up-to-90m-stake-heart-valve-anteris/810110/https://www.appliedclinicaltrialsonline.com/view/business-case-dei-pharmaceutical-innovation-organizational-commitment-inclusive-clinical-trialshttps://www.statnews.com/2026/01/21/what-psa-screening-gets-wrong-prostate-cancer/https://www.mobihealthnews.com/news/mayo-clinic-rethinking-brain-cancer-care-digital-transformationhttps://www.biospace.com/press-releases/taconic-biosciences-acquires-transcure-bioservices-building-a-comprehensive-global-platform-for-humanized-mouse-translational-researchhttps://www.modernhealthcare.com/events/mh-roi-profitability-playbook-parminder-bhatia-ge-healthcare/https://www.appliedclinicaltrialsonline.com/view/life-sciences-dei-startup-timelines-regulators-align-ai-governance
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Aucun commentaire pour le moment